Literature DB >> 17506949

Overexpression of coxsackie and adenovirus receptor inhibit growth of human bladder cancer cell in vitro and in vivo.

Lin-Lin Zhang1, Da-Lin He, Xiang Li, Lei Li, Guo-Dong Zhu, Dong Zhang, Xin-Yang Wang.   

Abstract

AIM: To study the effect of the overexpression of coxsackie and the adenovirus receptor (CAR) on the growth of the human bladder cancer cell in vitro and in vivo.
METHODS: A retroviral vector pLXSN-CAR expressing CAR was constructed and confirmed by restriction enzyme mapping. The pLXSN-CAR vector and control vector pLXSN were transfected into the PT67 packaging cell line to generate retrovirus with high titer. The CAR-negative T24 cell was infected with the pLXSN-CAR and the pLXSN retrovirus, respectively. The positive clone cells were selected with G418 for 2 weeks. The expression level of the CAR protein was detected by Western blot assay. T24 cell growth in vitro was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Anchorage-independent growth was measured by soft-agar colony formation assay. In vivo cell growth was determined by a nude mice xenograft model.
RESULTS: The pLXSN-CAR vector containing full-length CAR cDNA was successfully constructed. Western blot analysis showed that a 46 kDa specific band was found in pLXSN-CA-transfected T24 cells. MTT assay identified the growth inhibition of T24/pLXSN-CAR cells. The cell colony forming ability of T24/pLXSN-CAR cells was significantly lower than that of T24/pLXSN and parental T24 cells. There was a reduction in the tumor size in the T24/pLXSN-CAR group as compared with that of the T24/pLXSN group and parental T24 group.
CONCLUSION: The overexpression of CAR in T24 bladder cancer cells can inhibit cell growth both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17506949     DOI: 10.1111/j.1745-7254.2007.00574.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  8 in total

1.  Evaluation of tumor formation of three bladder cancer cell lines in nude mice.

Authors:  Fan Li; Zhangqun Ye; Weimin Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-04-20

2.  Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma.

Authors:  Min Yu; Zheng Tang; Fandi Meng; Minghui Tai; Jingyao Zhang; Ruitao Wang; Chang Liu; Qifei Wu
Journal:  Tumour Biol       Date:  2015-08-20

3.  Screen and analysis of key disease genes for precancerous lesions of oral buccal mucosa induced by DMBA in golden hamsters.

Authors:  Dan Chen; Kai Yang; Guodong Zhang; Jie Mei; Li Xiang
Journal:  Oncol Lett       Date:  2010-12-23       Impact factor: 2.967

4.  Upregulation of human DNA binding protein A (dbpA) in gastric cancer cells.

Authors:  Guo-rong Wang; Yan Zheng; Xiang-ming Che; Xin-yang Wang; Jia-hui Zhao; Kai-jie Wu; Jin Zeng; Chen-en Pan; Da-lin He
Journal:  Acta Pharmacol Sin       Date:  2009-09-14       Impact factor: 6.150

5.  Transcription factor Sp1 is involved in expressional regulation of coxsackie and adenovirus receptor in cancer cells.

Authors:  Sun-Ku Chung; Joo-Young Kim; Joong-Yeon Lim; Young Mi Park; Ha-Young Hwang; Jae-Hwan Nam; Sang Ick Park
Journal:  J Biomed Biotechnol       Date:  2011-11-24

6.  Antimicrobial peptide LL-37 promotes the proliferation and invasion of skin squamous cell carcinoma by upregulating DNA-binding protein A.

Authors:  Wei Wang; Jinjing Jia; Changji Li; Qiqi Duan; Jiao Yang; Xin Wang; Ruilian Li; Caifeng Chen; Huling Yan; Yan Zheng
Journal:  Oncol Lett       Date:  2016-07-15       Impact factor: 2.967

7.  Antimicrobial peptide LL-37 promotes YB-1 expression, and the viability, migration and invasion of malignant melanoma cells.

Authors:  Jinjing Jia; Yan Zheng; Wei Wang; Yongping Shao; Zhengxiao Li; Qiong Wang; Yuan Wang; Huling Yan
Journal:  Mol Med Rep       Date:  2016-12-02       Impact factor: 2.952

8.  Antimicrobial peptide LL-37 promotes the viability and invasion of skin squamous cell carcinoma by upregulating YB-1.

Authors:  Wei Wang; Yan Zheng; Jinjing Jia; Changji Li; Qiqi Duan; Ruilian Li; Xin Wang; Yongping Shao; Caifeng Chen; Huling Yan
Journal:  Exp Ther Med       Date:  2017-06-06       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.